The Dynamics of Glucose Metabolism Under Calcineurin Inhibitors in the First Year After Renal Transplantation in Nonobese Patients-Reference-Cited by-同舟云学术

The Dynamics of Glucose Metabolism Under Calcineurin Inhibitors in the First Year After Renal Transplantation in Nonobese Patients

Published:2007-07-15 Issue:1 Volume:84 Page:50-55
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:

Author:

David-Neto Elias,Lemos Francine C.,Fadel Luciana M.,Agena Fabiana,Sato Melissa Y.,Coccuza Christiano,Pereira Lilian M.,de Castro M Cristina R.,Lando Valeria S.,Nahas William C.,Ianhez Luiz E.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference24 articles.

1. Impact of diabetes mellitus on kidney transplant recipients in Spain.;Gonzalez-Posada;Nephrol Dial Transplant,2004

2. Guidelines for the treatment and management of new-onset diabetes after transplantation.;Wilkinson;Clin Transplant,2005

3. Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: A report of the European Tacrolimus Multicenter Renal Study Group.;Mayer;Transplantation,1997

4. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.;Pirsch;Transplantation,1997

5. Diabetogenic effect of tacrolimus in South African patients undergoing kidney transplantation1.;Panz;Transplantation,2002

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Perioperative glucose monitoring with continuous glucose monitors identifies risk factors for post-transplant diabetes mellitus in kidney transplant recipients;Scientific Reports;2024-09-11

2. Changes in glucose metabolism among recipients with diabetes 1 year after kidney transplant: a multicenter 1-year prospective study;Frontiers in Endocrinology;2023-06-21

3. Hyperglycemia and Diabetes in the Posttransplant Patient;Contemporary Endocrinology;2023

4. Sitagliptin Versus Placebo to Reduce the Incidence and Severity of Posttransplant Diabetes Mellitus After Kidney Transplantation—A Single-center, Randomized, Double-blind Controlled Trial;Transplantation;2022-10-20

5. Impaired TFEB activation and mitophagy as a cause of PPP3/calcineurin inhibitor-induced pancreatic β-cell dysfunction;Autophagy;2022-10-10